Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Carcinoma, Merkel Cell | 4 | 2018 | 35 | 1.23 | Why? |
| Germany | 23 | 2021 | 9196 | 0.98 | Why? |
| Skin Neoplasms | 8 | 2019 | 1679 | 0.95 | Why? |
| Early Detection of Cancer | 3 | 2018 | 1956 | 0.93 | Why? |
| Melanoma | 5 | 2019 | 1229 | 0.90 | Why? |
| Vascular Calcification | 4 | 2019 | 396 | 0.80 | Why? |
| Seminoma | 1 | 2018 | 16 | 0.76 | Why? |
| Testicular Neoplasms | 1 | 2018 | 91 | 0.67 | Why? |
| Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 106 | 0.67 | Why? |
| Death Certificates | 1 | 2019 | 130 | 0.67 | Why? |
| Epidemiologists | 1 | 2017 | 75 | 0.66 | Why? |
| Bed Occupancy | 1 | 2020 | 476 | 0.63 | Why? |
| International Classification of Diseases | 1 | 2019 | 265 | 0.62 | Why? |
| Observer Variation | 1 | 2018 | 622 | 0.61 | Why? |
| Kidney Function Tests | 1 | 2017 | 520 | 0.59 | Why? |
| Epidemiologic Studies | 1 | 2017 | 554 | 0.58 | Why? |
| Sick Leave | 1 | 2018 | 318 | 0.55 | Why? |
| Biomedical Technology | 1 | 2017 | 257 | 0.52 | Why? |
| Glomerular Filtration Rate | 1 | 2017 | 1262 | 0.45 | Why? |
| Intracranial Aneurysm | 1 | 2017 | 504 | 0.45 | Why? |
| National Health Programs | 1 | 2017 | 807 | 0.42 | Why? |
| Observational Studies as Topic | 1 | 2018 | 1887 | 0.42 | Why? |
| Government | 1 | 2020 | 1453 | 0.42 | Why? |
| Ecosystem | 1 | 2015 | 776 | 0.41 | Why? |
| Renal Insufficiency | 1 | 2017 | 810 | 0.41 | Why? |
| Intracranial Hemorrhages | 1 | 2018 | 1170 | 0.39 | Why? |
| Coronary Artery Disease | 4 | 2018 | 2570 | 0.37 | Why? |
| Mass Media | 1 | 2017 | 837 | 0.37 | Why? |
| Horse Diseases | 2 | 2019 | 101 | 0.36 | Why? |
| Parvoviridae Infections | 2 | 2019 | 222 | 0.34 | Why? |
| Cause of Death | 6 | 2021 | 4823 | 0.33 | Why? |
| Endovascular Procedures | 1 | 2017 | 1302 | 0.32 | Why? |
| Sleep Wake Disorders | 1 | 2018 | 1463 | 0.31 | Why? |
| Neoplasms | 3 | 2020 | 17251 | 0.29 | Why? |
| Blood Coagulation | 1 | 2018 | 2768 | 0.28 | Why? |
| Sleep | 1 | 2018 | 2695 | 0.28 | Why? |
| Life Expectancy | 2 | 2021 | 474 | 0.28 | Why? |
| Mass Screening | 3 | 2018 | 8005 | 0.26 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.26 | Why? |
| Aortic Diseases | 2 | 2019 | 362 | 0.26 | Why? |
| Public Health | 2 | 2020 | 16359 | 0.25 | Why? |
| Sex Distribution | 3 | 2021 | 2083 | 0.23 | Why? |
| Population Dynamics | 2 | 2017 | 378 | 0.23 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.22 | Why? |
| Patient Admission | 1 | 2018 | 5250 | 0.22 | Why? |
| Horses | 2 | 2019 | 474 | 0.22 | Why? |
| Hepatitis, Viral, Animal | 2 | 2019 | 274 | 0.22 | Why? |
| Sentinel Lymph Node Biopsy | 2 | 2019 | 173 | 0.21 | Why? |
| Incidence | 8 | 2018 | 25622 | 0.21 | Why? |
| Parvovirus | 1 | 2019 | 20 | 0.21 | Why? |
| Lymphoscintigraphy | 1 | 2019 | 18 | 0.20 | Why? |
| Vision Disorders | 1 | 2003 | 260 | 0.20 | Why? |
| Conjunctival Neoplasms | 1 | 2019 | 17 | 0.20 | Why? |
| Age Distribution | 3 | 2021 | 3567 | 0.20 | Why? |
| Proton Therapy | 1 | 2019 | 34 | 0.20 | Why? |
| Flaviviridae | 1 | 2019 | 60 | 0.20 | Why? |
| Humans | 50 | 2021 | 930598 | 0.19 | Why? |
| Spermatocytes | 1 | 2018 | 1 | 0.19 | Why? |
| Practice Patterns, Physicians' | 1 | 2018 | 4927 | 0.19 | Why? |
| Pathologists | 1 | 2020 | 168 | 0.19 | Why? |
| Sentinel Lymph Node | 1 | 2019 | 35 | 0.19 | Why? |
| Registries | 5 | 2019 | 12327 | 0.19 | Why? |
| Research Design | 1 | 2015 | 5830 | 0.19 | Why? |
| Klatskin Tumor | 1 | 2018 | 25 | 0.19 | Why? |
| Moles | 1 | 2018 | 4 | 0.19 | Why? |
| Influenza, Human | 2 | 2020 | 10779 | 0.18 | Why? |
| Seasons | 3 | 2021 | 4071 | 0.18 | Why? |
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2018 | 51 | 0.17 | Why? |
| Osteoradionecrosis | 1 | 2017 | 2 | 0.17 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.17 | Why? |
| Autopsy | 2 | 2020 | 3495 | 0.17 | Why? |
| Hantavirus Infections | 1 | 2018 | 62 | 0.17 | Why? |
| Hantavirus | 1 | 2018 | 63 | 0.17 | Why? |
| Coronary Disease | 2 | 2019 | 645 | 0.17 | Why? |
| Cerebrospinal Fluid Shunts | 1 | 2017 | 34 | 0.17 | Why? |
| Single Photon Emission Computed Tomography Computed Tomography | 1 | 2019 | 131 | 0.17 | Why? |
| Berlin | 1 | 2017 | 283 | 0.17 | Why? |
| Health Services Misuse | 1 | 2017 | 81 | 0.16 | Why? |
| Aorta, Thoracic | 1 | 2019 | 271 | 0.16 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.16 | Why? |
| Colonic Neoplasms | 1 | 2000 | 295 | 0.16 | Why? |
| Probability | 1 | 2020 | 923 | 0.16 | Why? |
| Bile Duct Neoplasms | 1 | 2018 | 172 | 0.15 | Why? |
| Europe | 5 | 2018 | 12702 | 0.15 | Why? |
| Hepatectomy | 1 | 2018 | 276 | 0.15 | Why? |
| Databases, Factual | 2 | 2021 | 6248 | 0.14 | Why? |
| Occupations | 1 | 2000 | 733 | 0.14 | Why? |
| Meat | 1 | 2017 | 380 | 0.14 | Why? |
| Male | 29 | 2021 | 367725 | 0.14 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.14 | Why? |
| Sweden | 1 | 2021 | 1969 | 0.14 | Why? |
| Carcinoma, Lobular | 1 | 2014 | 62 | 0.13 | Why? |
| Residence Characteristics | 2 | 2017 | 1927 | 0.13 | Why? |
| Middle Aged | 25 | 2021 | 270681 | 0.13 | Why? |
| Aged | 22 | 2021 | 215776 | 0.13 | Why? |
| Adenocarcinoma | 1 | 2000 | 651 | 0.13 | Why? |
| Female | 30 | 2021 | 380317 | 0.13 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.13 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.13 | Why? |
| Conjunctiva | 1 | 2019 | 620 | 0.12 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.12 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.12 | Why? |
| Carcinoma, Ductal, Breast | 1 | 2014 | 149 | 0.12 | Why? |
| Risk Assessment | 5 | 2021 | 25439 | 0.12 | Why? |
| Longitudinal Studies | 2 | 2018 | 9893 | 0.12 | Why? |
| Lymph Nodes | 1 | 2019 | 1060 | 0.12 | Why? |
| Risk Factors | 11 | 2021 | 71621 | 0.12 | Why? |
| Aged, 80 and over | 12 | 2021 | 88759 | 0.11 | Why? |
| Orthomyxoviridae | 1 | 2020 | 1168 | 0.11 | Why? |
| Health Services Research | 1 | 2017 | 756 | 0.11 | Why? |
| HIV Envelope Protein gp41 | 1 | 2012 | 153 | 0.11 | Why? |
| Computed Tomography Angiography | 2 | 2019 | 2153 | 0.11 | Why? |
| Disease Progression | 3 | 2019 | 13580 | 0.11 | Why? |
| Health Surveys | 2 | 2017 | 2841 | 0.11 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.11 | Why? |
| Carcinoma, Squamous Cell | 1 | 2019 | 902 | 0.10 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.10 | Why? |
| Coronary Angiography | 2 | 2018 | 2275 | 0.10 | Why? |
| Prevalence | 4 | 2019 | 25773 | 0.10 | Why? |
| Dental Care | 1 | 2017 | 795 | 0.10 | Why? |
| Urban Health | 1 | 2012 | 382 | 0.09 | Why? |
| Protein Engineering | 1 | 2012 | 536 | 0.09 | Why? |
| Preoperative Care | 1 | 2018 | 1515 | 0.09 | Why? |
| Time Factors | 6 | 2019 | 31397 | 0.09 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.09 | Why? |
| Tomography, X-Ray Computed | 6 | 2020 | 25144 | 0.09 | Why? |
| Point-of-Care Testing | 1 | 2020 | 2782 | 0.08 | Why? |
| Cell Membrane | 1 | 2012 | 743 | 0.08 | Why? |
| Lymphatic Metastasis | 2 | 2019 | 537 | 0.08 | Why? |
| Adult | 15 | 2021 | 244371 | 0.08 | Why? |
| Neoplasm Staging | 3 | 2019 | 1999 | 0.08 | Why? |
| Forecasting | 2 | 2017 | 4492 | 0.08 | Why? |
| Vulnerable Populations | 1 | 2020 | 3099 | 0.08 | Why? |
| Unemployment | 1 | 2012 | 702 | 0.08 | Why? |
| Parainfluenza Virus 3, Human | 1 | 2005 | 67 | 0.08 | Why? |
| Croup | 1 | 2005 | 44 | 0.07 | Why? |
| Perception | 1 | 2017 | 2827 | 0.07 | Why? |
| Periodicals as Topic | 1 | 2018 | 1492 | 0.07 | Why? |
| Phylogeny | 3 | 2019 | 13341 | 0.07 | Why? |
| Occupational Diseases | 1 | 2000 | 2787 | 0.07 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2019 | 11304 | 0.07 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.07 | Why? |
| Serologic Tests | 1 | 2019 | 4359 | 0.07 | Why? |
| Health Promotion | 1 | 2018 | 2020 | 0.07 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.07 | Why? |
| Head and Neck Neoplasms | 1 | 2017 | 1568 | 0.07 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.07 | Why? |
| Colorectal Neoplasms | 1 | 2017 | 1884 | 0.07 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.06 | Why? |
| Disease-Free Survival | 2 | 2019 | 1654 | 0.06 | Why? |
| Survival Rate | 4 | 2019 | 9206 | 0.06 | Why? |
| Age Factors | 3 | 2019 | 21039 | 0.06 | Why? |
| Spain | 1 | 2021 | 15545 | 0.06 | Why? |
| Liver Transplantation | 1 | 2018 | 2864 | 0.06 | Why? |
| Sampling Studies | 1 | 2003 | 386 | 0.06 | Why? |
| Prospective Studies | 4 | 2021 | 43301 | 0.06 | Why? |
| Infant | 3 | 2021 | 30274 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.06 | Why? |
| Calcinosis | 1 | 2004 | 240 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2020 | 4273 | 0.06 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.05 | Why? |
| Population Surveillance | 1 | 2018 | 4967 | 0.05 | Why? |
| Pulmonary Embolism | 1 | 2020 | 4775 | 0.05 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| Infant, Newborn | 2 | 2020 | 23105 | 0.05 | Why? |
| Sleep Initiation and Maintenance Disorders | 1 | 2012 | 1692 | 0.05 | Why? |
| Breeding | 1 | 2019 | 60 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.05 | Why? |
| Cholangiography | 1 | 2018 | 19 | 0.05 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2018 | 10649 | 0.05 | Why? |
| Hepatic Artery | 1 | 2018 | 31 | 0.05 | Why? |
| Italy | 2 | 2021 | 38444 | 0.05 | Why? |
| Merkel cell polyomavirus | 1 | 2017 | 5 | 0.05 | Why? |
| Bile Ducts | 1 | 2018 | 84 | 0.05 | Why? |
| Equivalence Trials as Topic | 1 | 2019 | 242 | 0.05 | Why? |
| Antibody Formation | 1 | 2012 | 4038 | 0.05 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2005 | 846 | 0.04 | Why? |
| United Kingdom | 1 | 2018 | 18046 | 0.04 | Why? |
| Mental Disorders | 1 | 2020 | 6742 | 0.04 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.04 | Why? |
| Cross-Sectional Studies | 3 | 2020 | 53120 | 0.04 | Why? |
| SEER Program | 1 | 2017 | 146 | 0.04 | Why? |
| Treatment Outcome | 3 | 2019 | 51732 | 0.04 | Why? |
| HIV-1 | 1 | 2012 | 3365 | 0.04 | Why? |
| United States | 3 | 2019 | 46150 | 0.04 | Why? |
| Portal Vein | 1 | 2018 | 193 | 0.04 | Why? |
| Geography, Medical | 1 | 2019 | 537 | 0.04 | Why? |
| Radiotherapy, Intensity-Modulated | 1 | 2017 | 148 | 0.04 | Why? |
| Predictive Value of Tests | 3 | 2019 | 9537 | 0.04 | Why? |
| Follow-Up Studies | 4 | 2019 | 17020 | 0.04 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2017 | 6166 | 0.04 | Why? |
| Breast Neoplasms | 1 | 2014 | 3633 | 0.04 | Why? |
| Antibodies, Viral | 3 | 2019 | 51949 | 0.04 | Why? |
| Neoadjuvant Therapy | 1 | 2018 | 554 | 0.04 | Why? |
| Prognosis | 5 | 2019 | 32490 | 0.04 | Why? |
| Geography | 1 | 2021 | 1801 | 0.04 | Why? |
| Chemoradiotherapy | 1 | 2017 | 362 | 0.03 | Why? |
| Child | 2 | 2021 | 70012 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2021 | 23402 | 0.03 | Why? |
| Psychiatric Status Rating Scales | 1 | 2020 | 1340 | 0.03 | Why? |
| Health Services Accessibility | 1 | 2017 | 10697 | 0.03 | Why? |
| False Positive Reactions | 1 | 2019 | 1338 | 0.03 | Why? |
| Neoplasm Grading | 1 | 2014 | 400 | 0.03 | Why? |
| False Negative Reactions | 1 | 2019 | 1785 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2019 | 2437 | 0.03 | Why? |
| Animals | 5 | 2019 | 78931 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| Multivariate Analysis | 2 | 2017 | 5440 | 0.03 | Why? |
| Virion | 1 | 2019 | 1444 | 0.03 | Why? |
| Neoplasm Metastasis | 1 | 2014 | 682 | 0.03 | Why? |
| Linear Models | 1 | 2017 | 1914 | 0.03 | Why? |
| Educational Status | 1 | 2017 | 1451 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.03 | Why? |
| Cohort Studies | 3 | 2019 | 36005 | 0.02 | Why? |
| Ethiopia | 1 | 2014 | 1222 | 0.02 | Why? |
| Vaccines, Virus-Like Particle | 1 | 2012 | 312 | 0.02 | Why? |
| Hypertension, Pulmonary | 1 | 2018 | 970 | 0.02 | Why? |
| Odds Ratio | 1 | 2000 | 5861 | 0.02 | Why? |
| Logistic Models | 1 | 2003 | 9089 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2019 | 6543 | 0.02 | Why? |
| Molecular Sequence Data | 1 | 2012 | 3198 | 0.02 | Why? |
| Genome, Viral | 2 | 2019 | 13157 | 0.02 | Why? |
| Hemorrhage | 1 | 2018 | 3013 | 0.02 | Why? |
| Survival Analysis | 1 | 2019 | 7592 | 0.02 | Why? |
| Combined Modality Therapy | 1 | 2014 | 3395 | 0.02 | Why? |
| Respiratory Tract Infections | 1 | 2005 | 6817 | 0.02 | Why? |
| Immunization, Secondary | 1 | 2012 | 1649 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2019 | 6740 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2018 | 3691 | 0.02 | Why? |
| Liver | 1 | 2018 | 4007 | 0.02 | Why? |
| Immunotherapy | 1 | 2017 | 2421 | 0.02 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.02 | Why? |
| Viral Load | 2 | 2019 | 15850 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.01 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.01 | Why? |
| Occupational Exposure | 1 | 2000 | 4742 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2018 | 43792 | 0.01 | Why? |
| DNA, Viral | 1 | 2012 | 2521 | 0.01 | Why? |
| Case-Control Studies | 1 | 2000 | 17671 | 0.01 | Why? |
| Peptide Fragments | 1 | 2012 | 2075 | 0.01 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.01 | Why? |
| Amino Acid Sequence | 1 | 2012 | 6049 | 0.01 | Why? |
| HEK293 Cells | 1 | 2012 | 8394 | 0.01 | Why? |
| Exercise Test | 1 | 2004 | 911 | 0.01 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2018 | 11041 | 0.01 | Why? |
| Retrospective Studies | 3 | 2019 | 105322 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.01 | Why? |
| Coronavirus | 1 | 2005 | 18339 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2012 | 8495 | 0.01 | Why? |
| Comorbidity | 1 | 2018 | 34796 | 0.01 | Why? |
| Mice | 1 | 2012 | 21357 | 0.01 | Why? |
| Outpatients | 1 | 2005 | 3417 | 0.01 | Why? |
| Risk | 1 | 2004 | 5288 | 0.01 | Why? |
| Mutation | 1 | 2012 | 12376 | 0.01 | Why? |
| Inpatients | 1 | 2005 | 5161 | 0.01 | Why? |
| Myocardial Infarction | 1 | 2004 | 3361 | 0.01 | Why? |